According to FutureWise analysis the market for histopathology services in 2023 was US$ 26.8 billion, and is expected to reach US$ 42.46 billion by 2031 at a CAGR of 5.92%. The growth in histopathology services can be attributed to the rising incidence of cancer and other chronic diseases that necessitate precise tissue-based diagnostics. Additionally, advancements in digital pathology and AI-powered image analysis, along with the expansion of laboratory services in emerging economies, are significantly contributing to the global demand for these services.
Histopathology refers to the microscopic examination of tissue to identify abnormalities that may indicate disease. This branch of medicine is vital in clinical settings, providing preliminary diagnoses for various medical conditions. By assessing tissue samples, histopathology assists in determining the pharmacological, toxicological, and therapeutic effectiveness of medical treatments. The process includes sample collection, on-site processing, and comparison of diseased tissues to healthy ones, making it an essential diagnostic tool for detecting a wide array of ailments, particularly cancer.
The histopathology market encompasses various products and services related to the preparation, staining, and analysis of tissue samples. As healthcare continues to evolve, there is a pressing need for innovation in preliminary disease diagnosis, which is crucial for effective disease management. The demand for histopathology services is growing, driven by rising awareness of the importance of early diagnosis and government funding aimed at developing advanced diagnostic tools.
In the Middle East and North Africa (MENA) region, the histopathology market is forecasted to witness significant growth. This expansion is fueled by increased recognition of the need for early disease diagnosis and treatment, a rising demand for sophisticated diagnostic modalities, and the introduction of new technologies. Concerningly, the World Health Organization (WHO) projects a 40% rise in cancer incidence in the MENA region by 2025, escalating the need for histopathology services that are critical for accurate diagnosis and therapeutic intervention. The growth of the market is also supported by the increasing number of hospitals and diagnostic centers in the region, along with a rise in healthcare professionals. Furthermore, government initiatives promoting advanced diagnostic techniques and collaborations between healthcare providers and research institutions significantly contribute to this expansion.
However, the histopathology market in the MENA region does face some challenges. A notable issue is the shortage of qualified histopathologists, which can result in delays in diagnosis and treatment. Additionally, the high cost of histopathology services may pose a barrier for patients, especially in low-income areas.
FutureWise Market Research has published a report that provides an insightful analysis of Histopathology Services Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=17&type=requestsample
Histopathology Services Market Segmentation:
By Product and Services
- Products
- Instruments
- Tissue processor equipment
- Tissue embedding equipment
- Slide strainers systems
- Cover slipper systems
- Microtome & cryostat
- Microscopes
- Others
- Consumables
- Instruments
- Service
- Surgical Specimen Examination
- Biopsies
- Bone Marrow Biopsy Tissue Examination
- Breast Core Biopsy Tissue Examination
- Skin Biopsy, Kidney Biopsy Tissue Examination
- Liver Biopsy Tissue Examination
- Bile Duct Brushing
- Cytology
- Others
By Application
- Clinical/Diagnostic
- Research
By End User
- Hospital based laboratories
- Laboratories
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Histopathology Services Market:
- CPS Clinical Pathology Services
- SRL DIAGNOSTICS FZ-LLC
- Medsol Diagnostic
- Cure
- Thumbay Labs
- Healthchecks360
- National Reference Laboratory
- Metropolis
- Pure Health LLC
- Eurofins Biominis
- Freiburg
- Unilabs
- Agiomix FZ LLC
- Thermo Fisher Scientific
- Hoffman-la-Roche Ltd.
- Leica Biosystems
- Agilent Technologies Inc
- Merck KGaA
- Abbott Laboratories
- Sakura Fintek
- Oxford Cancer Biomarkers
- Acculabs Diagnostics UK Ltd.
- Cellular Pathology Services Limited
- Great Ormond Street Hospital (GOSH) Laboratory
- HCA Laboratories UK
- Laboratoire Cerba
- Sonic Healthcare Limited
- Spire Healthcare Group Plc
- Targos Molecular Pathology GmbH
- TPL Path Labs
Recent developments by key players in Histopathology Services Market:
Leica Biosystems
- Enhanced performance for high-throughput labs in the Aperio GT 450 Digital Pathology Scanner was released in January 2025.
- Launched the HistoCore CHROMAX Workstation for advanced tissue processing and partnered with Molecular Instruments to introduce integrated RNA-ISH staining with its BOND RX systems.
Abbott
- Abbott's Core Laboratory division takes an active role in events such as the Annual Meeting of the Association for Diagnostic and Laboratory Medicine (ADLM), where it showcases innovations in laboratory systems and technologies. For example, presentations on the transformation of core labs through Good Laboratory Practices (GLP) systems demonstrate Abbott's commitment to improving laboratory operations and diagnostics.
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=17&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Histopathology Services Market By Product and Services, By Application, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
